Relating to prescription drugs; and prescribing an effective date.

Requires pharmacy benefit managers to annually report to Department of Consumer and Business Services information about certain rebates, fees, price protection payments and other payments received from prescription drug manufacturers. Requires department to publish aggregated information received from pharmacy benefit managers on department's website. Requires Prescription Drug Affordability Board to develop, and to report on to interim committees of Legislative Assembly related to health by September 15, 2024, plan for establishing upper payment limits on certain drugs. Provides that plan must include analysis of how upper payment limits could be implemented by Public Employees' Benefit Board, Oregon Educators Benefit Board, other state-administered health benefits and insurance. Provides that report must include analysis of potential savings or costs for state, insurers, hospitals, pharmacies and consumers. Continuously appropriates moneys in Prescription Drug Affordability Account to department. Modifies requirements for reports submitted to department by prescription drug manufacturers. ] Makes confidential and not subject to disclosure information reported by prescription drug manufacturer that includes personally identifiable information about consumer. Expands membership of Prescription Drug Affordability Board. Modifies information that department must provide to board. Limits information that insurer must report to department regarding prescription drugs covered by insurer to coverage provided under health benefit plans. Takes effect on 91st day following adjournment sine die.